AAAAAA
Results: 1-25/53
Authors:
Ten Hagen, TLM
Seynhaeve, ALB
Van Tiel, ST
Ruiter, DJ
Eggermont, AMM
Citation: Tlm. Ten Hagen et al., Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, INT J CANC, 97(1), 2002, pp. 115-120
Authors:
ten Hagen, TLM
Eggermont, AMM
Lejeune, FL
Citation: Tlm. Ten Hagen et al., TNF is here to stay - revisited, TRENDS IMMU, 22(3), 2001, pp. 127-129
Authors:
de Wilt, JHW
Bout, A
Eggermont, AMM
van Tiel, ST
de Vries, MW
ten Hagen, TLM
de Roos, WK
Valerio, D
van der Kaaden, ME
Citation: Jhw. De Wilt et al., Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats, HUM GENE TH, 12(5), 2001, pp. 489-502
Authors:
Eggermont, AMM
Citation: Amm. Eggermont, The role interferon-alpha in malignant melanoma remains to be defined, EUR J CANC, 37(17), 2001, pp. 2147-2153
Authors:
Ruiter, DJ
Testori, A
Eggermont, AMM
Punt, CJA
Citation: Dj. Ruiter et al., The AJCC staging proposal for cutaneous melanoma: Comments by the EORTC Melanoma Group, ANN ONCOL, 12(1), 2001, pp. 9-11
Authors:
Vrouenraets, BC
Eggermont, AMM
Hart, AAM
Klaase, JM
van Geel, AN
Nieweg, OE
Kroon, BBR
Citation: Bc. Vrouenraets et al., Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor-alpha versus toxicity after melphalan alone, EUR J SUR O, 27(4), 2001, pp. 390-395
Authors:
Koelemij, R
Hagenaars, M
Ensink, NG
Eggermont, AMM
Van De Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: R. Koelemij et al., Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration, SC J IMMUN, 53(3), 2001, pp. 277-281
Authors:
Eggermont, AMM
Citation: Amm. Eggermont, Frontiers in adjuvant therapy in stage II-III melanoma, TUMORI, 87(4), 2001, pp. S60-S63
Authors:
de Vries, TJ
Smeets, M
de Graaf, R
Hou-Jensen, K
Brocker, EB
Renard, N
Eggermont, AMM
van Muijen, GNP
Ruiter, DJ
Citation: Tj. De Vries et al., Expression of gp100, MART-I, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group, J PATHOLOGY, 193(1), 2001, pp. 13-20
Authors:
Obertop, H
Eggermont, AMM
Neoptolemos, JP
Citation: H. Obertop et al., Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial - Discussion, ANN SURG, 234(6), 2001, pp. 768-768
Authors:
Eggermont, AMM
Weber, JC
Citation: Amm. Eggermont et Jc. Weber, Analysis of allelic imbalance in patients with colorectal cancer accordingto stage and presence of synchronous liver metastases - Discussion, ANN SURG, 234(6), 2001, pp. 802-803
Authors:
van Ijken, MGA
van Etten, B
de Wilt, JHW
van Tiel, ST
ten Hagen, TLM
Eggermont, AMM
Citation: Mga. Van Ijken et al., Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model, J IMMUNOTH, 23(4), 2000, pp. 449-455
Authors:
Eggermont, AMM
Citation: Amm. Eggermont, TNF registered in Europe: Does TNF get a second chance?, J IMMUNOTH, 23(4), 2000, pp. 505-506
Authors:
Keilholz, U
Eggermont, AMM
Citation: U. Keilholz et Amm. Eggermont, The role of interleukin-2 in the management of stage IV melanoma: The EORTC Melanoma Cooperative Group program, CA J SCI AM, 6, 2000, pp. S99-S103
Authors:
Stam, TC
Swaak, AJG
de Vries, MR
ten Hagen, TLM
Eggermont, AMM
Citation: Tc. Stam et al., Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage, ANN SURG O, 7(4), 2000, pp. 268-275
Authors:
Kruit, WHJ
Eggermont, AMM
Stoter, G
Citation: Whj. Kruit et al., Interferon-alpha induced Raynaud's syndrome, ANN ONCOL, 11(11), 2000, pp. 1501-1502
Authors:
de Kanter, AY
van Geel, AN
Paul, MA
van Eijck, CHJ
Henzen-Logmans, SC
Kruyt, RH
Krenning, EP
Eggermont, AMM
Wiggers, T
Citation: Ay. De Kanter et al., Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control, EUR J SUR O, 26(7), 2000, pp. 652-656
Authors:
Hagenaars, M
Ensink, NG
Eggermont, AMM
van der Velde, EA
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: M. Hagenaars et al., Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model, CANCER IMMU, 48(10), 2000, pp. 561-568
Authors:
Hagenaars, M
Koelemij, R
Ensink, NG
van Eendenburg, JDH
van Vlierberghe, RLP
Eggermont, AMM
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: M. Hagenaars et al., The development of novel mouse monoclonal antibodies against the CC531 ratcolon adenocarcinoma, CLIN EXP M, 18(4), 2000, pp. 281-289
Authors:
Hagenaars, M
Ensink, NG
Basse, PH
Hokland, M
Nannmark, U
Eggermont, AMM
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: M. Hagenaars et al., The microscopic anatomy of experimental rat CC531 colon tumour metastases:Consequences for immunotherapy?, CLIN EXP M, 18(2), 2000, pp. 189-196
Authors:
Van der Veen, AH
Ten Hagen, TLM
De Wilt, JHW
Van Ijken, MGA
Eggermont, AMM
Citation: Ah. Van Der Veen et al., An overview on the use of TNF-alpha: Our exprerience with regional administration and developments towards new opportunities for systemic application, ANTICANC R, 20(5B), 2000, pp. 3467-3474
Authors:
De Wilt, JHW
Soma, GI
Ten Hagen, TLM
Kanou, J
Takagi, K
Nooijen, PTGA
Seynhaevel, ALB
Eggermont, AMM
Citation: Jhw. De Wilt et al., Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats, ANTICANC R, 20(5B), 2000, pp. 3491-3496
Authors:
Eggermont, AMM
van IJken, MGA
van Etten, B
van der Sijp, JRM
ten Hagen, TLM
Wiggers, T
Oudkerk, M
de Boeck, G
de Bruijn, EA
Citation: Amm. Eggermont et al., Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: From laboratory to the clinic towards a percutaneous procedure, HEP-GASTRO, 47(33), 2000, pp. 776-781
Authors:
Jonges, LE
Giezeman-Smits, KM
van Vlierberghe, RLP
Ensink, NG
Hagenaars, M
Joly, E
Eggermont, AMM
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: Le. Jonges et al., NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis, IMMUNOBIOL, 202(4), 2000, pp. 326-338
Authors:
Keilholz, U
Eggermont, AMM
Citation: U. Keilholz et Amm. Eggermont, The emerging role of cytokines in the treatment of advanced melanoma, ONCOL-BASEL, 58(2), 2000, pp. 89-95